Organic Letters
Letter
Tetrahedron Lett. 1984, 25, 1383−1386. (c) Noyori, R.; Suzuki, M.
Angew. Chem., Int. Ed. Engl. 1984, 23, 847−876. (d) Suzuki, M.;
Yanagisawa, A.; Noyori, R. Tetrahedron Lett. 1983, 24, 1187−1188.
(6) (a) Heng, K. K.; Smith, R. A. J. Tetrahedron 1979, 35, 425−435.
(b) Suzuki, M.; Kawagishi, T.; Suzuki, T.; Noyori, R. Tetrahedron Lett.
1982, 23, 4057−4060. (c) Yamada, K. I.; Arai, T.; Sasai, H.; Shibasaki,
M. J. Org. Chem. 1998, 63, 3666−3672. (d) Lipshutz, B. H.; Wood, M.
R. J. Am. Chem. Soc. 1994, 116, 11689−11702.
Scheme 7. Comparison of the Remote Stereoinduction of
OTBS in (S)-6 versus OBoc in (R)-10
(7) (a) Nicolaou, K. C.; Tang, W.; Dagneau, P.; Faraoni, R. Angew.
Chem., Int. Ed. 2005, 44, 3874−3879. (b) Kobayashi, Y.; Murugesh, M.
G.; Nakano, M.; Takahisa, E.; Usmani, S. B.; Ainai, T. J. Org. Chem.
2002, 67, 7110−7123. (c) Arnold, L. A.; Naasz, R.; Minnaard, A. J.;
Feringa, B. L. J. Org. Chem. 2002, 67, 7244−7254.
(8) Noyori, R.; Suzuki, M.; Kurozumi, S. (Jpn. Kokai Tokkyo Koho),
JPA 19860613, 1986.
(9) (a) Ulbrich, K.; Kreitmeier, P.; Reiser, O. Synlett 2010, 13, 2037−
2040. (b) Ulbrich, K.; Kreitmeier, P.; Vilaivan, T.; Reiser, O. J. Org.
Chem. 2013, 78, 4202−4206. (c) Trost, B. M.; Toste, F. D. J. Am.
Chem. Soc. 1999, 121, 3543−3544. (d) Trost, B. M.; Masters, J. T.;
Lumb, J. P.; Fateen, D. Chem. Sci. 2014, 5, 1354−1360.
(10) (a) Suzuki, M.; Suzuki, T.; Kawagishi, M.; Noyori, R.
Tetrahedron Lett. 1980, 21, 1247−1250. (b) Suzuki, M.; Kawagishi,
T.; Yanagisawa, A.; Suzuki, T.; Okamura, N.; Noyori, R. Bull. Chem.
Soc. Jpn. 1988, 61, 1299−1312. (c) Lipshutz, B. H.; Wilhelm, R. S.;
Kozlowski, J. A. J. Org. Chem. 1984, 49, 3938−3942. (d) Knochel, P.;
Dohle, W.; Gommermann, N.; Kneisel, F. F.; Kopp, F.; Korn, T.;
Sapountzis, I.; Vu, V. A. Angew. Chem., Int. Ed. 2003, 42, 4302−4320.
(e) Kobayashi, Y.; Nakada, M. Angew. Chem., Int. Ed. 2013, 52, 7569−
architecture. The methodology described here offers a versatile
approach for the asymmetric synthesis of chiral five-membered
carbocycles, being ubiquitous constituents in natural products
and drugs.
ASSOCIATED CONTENT
* Supporting Information
■
S
Experimental details can be found in the Supporting
Information (procedures, analytical data, copies of NMR and
HPLC spectra). This material is available free of charge via the
7573. (f) Alexakis, A.; Backvall, J. E.; Krause, N.; Pam
́
ies, O.; Dieg
́
uez,
̈
M. Chem. Rev. 2008, 108, 2796−2823.
(11) (a) Schelwies, M.; Dubon, P.; Helmchen, G. Angew.Chem., Int.
̈
Ed. 2006, 45, 2466−2469. (b) Chen, M.; Hartwig, J. F. Angew. Chem.,
̇
́
Int. Ed. 2014, 53, 8691−8695. (c) Zurawinski, R.; Mikina, M.;
Mikołajczyk, M. Tetrahedron: Asymmetry 2010, 21, 2794−2799.
(d) Iqbal, M.; Evans, P. Tetrahedon Lett. 2003, 44, 5741−5745.
(e) Weaving, R.; Roulland, E.; Monneret, C.; Florent, J. C. Tetrahedron
Lett. 2003, 44, 2579−2581. (f) Sugiura, M.; Kinoshita, R.; Nakajima,
M. Org. Lett. 2014, 16, 5172−5175.
(12) (a) Schall, A.; Reiser, O. Eur. J. Org. Chem. 2008, 2353−2364.
(b) Fraga, B. M. Nat. Prod. Rep. 2007, 24, 1350−1381. (c) Gao, F.;
Wang, H.; Mabry, T. J.; Bierner, M. W. Phytochemistry 1990, 29, 895−
899.
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
This work was supported by the Deutsche Akademische
Austauschdienst DAAD (fellowship for A.N.).
■
(13) (a) Chhor, R. B.; Nosse, B.; Sorgel, S.; Bohm, C.; Seitz, M.;
̈
̈
Reiser, O. Chem.Eur. J. 2003, 9, 260−270. (b) Nosse, B.; Chhor, R.
B.; Jeong, W. B.; Bohm, C.; Reiser, O. Org. Lett. 2003, 5, 941−944.
̈
(c) Bohm, C.; Schinnerl, M.; Bubert, C.; Zabel, M.; Labahn, T.;
̈
REFERENCES
■
Parisini, E.; Reiser, O. Eur. J. Org. Chem. 2000, 2955−2965.
(14) Hanessian, S.; Giroux, S.; Larsson, A. Org. Lett. 2006, 8, 5481−
5484.
(1) Leading Review: Aitken, D. J.; Eijsberg, H.; Frongia, A.; Ollivier, J.;
Piras, P. P. Synthesis 2014, 46, 1−24.
(2) Kato, T.; Fukushima, M.; Kurozumi, S.; Noyori, R. Cancer Res.
1986, 46, 3538−3542.
(15) (a) Dowling, M. S.; Vanderwal, C. D. J. Am. Chem. Soc. 2009,
131, 15090−15091. (b) Dowling, M. S.; Vanderwal, C. D. J. Org.
Chem. 2010, 75, 6908−6922.
(3) (a) Sasaki, H.; Niimi, S.; Akiyama, M.; Tanaka, T.; Hazato, A.;
Kurozumi, S.; Fukushima, S.; Fukushima, M. Cancer Res. 1999, 59,
3919−3922. (b) Fukushima, S.; Takeuchi, Y.; Kishimoto, S.;
Yamashita, S.; Uetsuki, K.; Shirakawa, S.; Suzuki, M.; Furuta, K.;
Noyori, R.; Sasaki, H.; Kikuchi, Y.; Kita, T.; Yamori, T.; Sawada, J.;
Kojima, M.; Hazato, A.; Kurozumi, S.; Fukushima, M. Anti-Cancer
Drugs 2001, 12, 221−234. (c) Fukushima, S.; Kishimoto, S.; Takeuchi,
Y.; Fukushima, M. Drug Delivery Rev. 2000, 45, 65−75. (d) Furuta, K.;
Tomokiyo, K.; Satoh, T.; Watanabe, Y.; Suzuki, M. ChemBioChem
2000, 1, 283−286. (e) Furuta, K.; Maeda, M.; Hirata, Y.; Shibata, S.;
Kiuchi, K.; Suzuki, M. Bioorg. Med. Chem. Lett. 2007, 17, 5487−5491.
(4) (a) Cheng, X.; Zeng, Q.; Ren, J.; Qin, J.; Zhang, S.; Shen, Y.; Zhu,
J.; Zhang, F.; Chang, R.; Zhu, Y.; Zhang, W.; Jin, H. Eur. J. Med. Chem.
2011, 46, 5408−5415. (b) Bruno, M.; Tore, M. C.; Rodriguez, B.;
Omar, A. A. Phytochemistry 1993, 34, 245−247. (c) Ziaei, A.;
Amirghofran, Z.; Zapp, J.; Ramezani, M. Iran. J. Immunol. 2011, 8,
226−235.
(5) (a) Suzuki, M.; Kawagishi, T.; Noyori, R. Tetrahedron Lett. 1982,
23, 5563−5566. (b) Suzuki, M.; Yanagisawa, A.; Noyori, R.
D
dx.doi.org/10.1021/ol5032975 | Org. Lett. XXXX, XXX, XXX−XXX